Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes

Clinical trial NCT05908682 · RECRUITING

Trial details

NCT number: NCT05908682
Sponsor: Scynexis, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Vulvovaginal Candidiasis Candida Infection Vaginal Candidiasis

Start date: 2022-07-28
Primary completion: 2029-10-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.